Internal Medicine, Transplant Hepatology · Tampa, FL
NPI
1639332166
Since 2008
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
409 Bayshore Blvd
Tampa, FL, 33606
Phone (813) 844-5460
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
582 services
Medicare patients, 2024
243
Average age 66
Drug cost, 2024
$1.5M
1,958 prescriptions
Company payments, 2025
$120
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kawtar Al Khalloufi was code 99233 (hospital e&m - subsequent), 299 times for 85 patients. In total Kawtar Al Khalloufi billed 582 services in 17 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 299 | 85 | $91.83 | $27K |
| 99215 Office E&M - Established | Office | 69 | 53 | $98.36 | $6,787 |
| 99223 Hospital E&M - Initial | Facility | 52 | 48 | $130.30 | $6,776 |
| 99232 Hospital E&M - Subsequent | Facility | 37 | 28 | $59.00 | $2,183 |
| 99443 Telephone Services | Office | 32 | 31 | $73.27 | $2,345 |
| 99214 Office E&M - Established | Office | 21 | 19 | $72.53 | $1,523 |
| 99205 Office E&M - New | Office | 21 | 21 | $121.32 | $2,548 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $102.20 | $1,635 |
| 99204 Office E&M - New | Office | 14 | 14 | $82.84 | $1,160 |
By year: 2022 $52K for 593 services; 2023 $59K for 641 services; 2024 $53K for 582 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kawtar Al Khalloufi prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 322 prescriptions and refills. In total Kawtar Al Khalloufi wrote 1,958 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 322 | 322 | 49 | $997K |
| Tacrolimus Generic | 261 | 508 | 104 | $34K |
| Ursodiol Generic | 150 | 276 | 46 | $22K |
| Carvedilol Generic | 150 | 266 | 44 | $585 |
| Furosemide Generic | 143 | 257 | 42 | $491 |
| Spironolactone Generic | 137 | 258 | 45 | $1,619 |
| Mycophenolate Mofetil Generic | 136 | 290 | 60 | $12K |
| Envarsus Xr Tacrolimus | 76 | 124 | 26 | $89K |
| Lactulose Generic | 73 | 104 | 27 | $2,713 |
| Entecavir Generic | 56 | 93 | 17 | $11K |
| Azathioprine Generic | 55 | 85 | Under 11 | $881 |
| Vemlidy Tenofovir Alafenamide | 42 | 42 | Under 11 | $58K |
| Prednisone Generic | 41 | 83 | 24 | $211 |
| Amiloride Hcl Generic | 34 | 39 | Under 11 | $385 |
| Mycophenolic Acid Mycophenolate Sodium | 34 | 78 | 21 | $6,537 |
Brand drugs: 635 claims; generic drugs: 1,323 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kawtar Al Khalloufi $120 ($120 in general payments such as food, travel and fees) from 1 company. The largest payer was Novo Nordisk Inc with $120.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 1 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.